knowledge -WSS

knowledge

author：knowledge 2025-09-06 04:37:19 - browse：54127

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Ionis has late

entertainment

WSS

Intercept Pharmaceuticals sells itself for less than $1 billion

Inequities make cancer less preventable for women: report

BIO selects John Crowley as new CEO

Flagship Pioneering launches a new biotech in two countries

FDA seeks to regulate lab

Paxlovid should be available without a positive Covid test

focus

knowledge

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Mayo Clinic plans $5B tech

Wildfire smoke exposes gaps in outdoor worker protections

Fetal surgery at risk from Dobbs and new abortion restrictions

Alkermes shareholders re

Address the ethical violations that led to 'Three Identical Strangers'

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Researchers use wearables data and AI to predict preterm birth risk

United colonoscopy coverage change 'may cost lives,' doctors say

Cigna to pay $172 million to settle Medicare Advantage fraud probe

leisure time

Medicare drug price negotiation program allowed for now

Ionis has late

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Why do women spend more than men on medical expenses?

Medicaid, Medicare dual

hotspot

hotspot

entertainment

Wikipedia